Global Neurogenetic Testing market size is expected to reach $1.24 billion by 2030 at 11.9%, segmented as by microarray analysis, comparative genomic hybridization (cgh) microarray, single nucleotide polymorphism (snp) microarray
Read More
The global Gene Transplant market size is expected to reach $7.57 billion in 2030 at 12.8%, driven by rise in gene therapy adoption.
Read More
The Gene Transfer Technologies market size is expected to reach $8.77 billion in 2030 at 14%, driven by growing adoption of advanced gene delivery systems.
Read More
Global Neurofibromatosis Type 1 market size is expected to reach $13.78 billion by 2030 at 9.2%, spontaneous (de novo) mutation driving the growth of the market
Read More
Global Neurofibromatosis Treatment market size is expected to reach $27.75 billion by 2030 at 13.5%, segmented as , surgical interventions, medication for symptom management, genetic counseling
Read More
The Gene Therapy Clinical Trial Services market size is expected to reach $4.39 billion in 2030 at 19.1%, driven by rising gene therapy trials, precision medicine adoption
Read More
The neurofeedback system market is projected to reach $2.61 billion by 2030, growing at 10.5% CAGR, driven by precision neurotherapy, AI-driven brain monitoring, and digital health integration.
Read More
The gene switch market is set to reach $1.8 billion by 2030, growing at a 14.0% CAGR, driven by gene therapies, precision gene regulation, and synthetic biology advances.
Read More
The neurofeedback market is set to reach $2.6 billion by 2030, growing at 10.5% CAGR, driven by personalized mental health care, digital therapeutics, and AI-based brain training.
Read More
Global Gene Panel market size is expected to reach $4.96 billion by 2030 at 14.9%, growing cancer prevalence driving expansion of the market
Read More